NRG Energy, Inc.
http://www.nrgenergy.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NRG Energy, Inc.
Gilead Waives Acquisition Option As Pionyr Explores Other Strategies
Gilead has waived its option to acquire Pionyr, allowing the US biotech to explore other partnerships and financing opportunities as it advances a promising pipeline of macrophage-targeting antibodies.
Complex Products At US FDA: Adamis' Epi-Pen Alternative OKed; Sandoz Advair ANDA Accepted
The latest regulatory news on new versions of complex products and delivery systems from our FDA Performance Tracker.
Complex Products At US FDA: Adamis' Epi-Pen Alternative OKed; Sandoz Advair ANDA Accepted
The latest regulatory news on new versions of complex products and delivery systems from our FDA Performance Tracker.
Deals In Depth: September 2014
Merrimack licensed Baxter its Phase III pancreatic cancer candidate MM398 for $100 million up front and $620 million in pre-commercial milestones; Merck KGAA added life sciences products in its $16.7 billion acquisition of Sigma-Aldrich. Biopharma and device financing were both up from the previous month.
Company Information
- Other Names / Subsidiaries
-
- Padoma Wind Power, NRG Thermal LLC, NRG Engine Services, Bluewater Wind, Green Mountain Energy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice